HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.


Highly active antiretroviral therapy (HAART) has been successful in delaying the progression to AIDS in HIV-1-infected individuals. Exposure to HAART can result in metabolic side effects, such as dyslipidemia, in a subset of recipients. Longitudinal data and frozen peripheral blood mononuclear cell pellets were obtained from 1,945 men enrolled in the… (More)
DOI: 10.1089/AID.2012.0169